GE HealthCare to Announce First Quarter 2024 Results on April 30, 2024

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

CHICAGO–(BUSINESS WIRE)–GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its first quarter 2024 financial results before the market opens on Tuesday, April 30, 2024. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay will also all be posted at the same link on the GE HealthCare Investor Relations website.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

Follow us on LinkedIn, X (formerly Twitter), and Insights for the latest news, or visit our website https://www.gehealthcare.com/ for more information.

Contacts

GE HealthCare Investor Contact
Carolynne Borders

631.662.4317

carolynne.borders@gehealthcare.com

GE HealthCare Media Contact
Tor Constantino

585.441.1658

tor.constantino@gehealthcare.com

Staff

Recent Posts

Vent Creativity℠ Receives FDA-Clearance for AI-Powered Digital-Twin Knee Arthroplasty Planning Tool, Hermes.

Vent’s new web-based software is now available for clinical use in the US, starting with…

4 hours ago

Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years

Investment builds on almost 140-year legacy of improving and saving lives and supporting American jobs…

4 hours ago

Genmab, NHS England, Pistoia Alliance and Regeneron Win Bio-IT World Innovative Practices Awards

Organizations to be Featured During Friday Sessions ofBio-IT World Conference & Expo, April 2-4 in…

4 hours ago

US Healthcare Analytics Market worth US$47.40 billion by 2029 with 24.5% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., March 21, 2025 /PRNewswire/ -- The global US Healthcare Analytics Market, valued at…

10 hours ago

Task Trainers Market to Reach $2.9 Billion by 2032–Exclusive Report by Meticulous Research®

REDDING, Calif., March 21, 2025 /PRNewswire/ -- According to a new market research report titled 'Task…

10 hours ago